Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Cantor Fitzgerald
Federal Trade Commission
Colorcon
QuintilesIMS
Teva
US Army
Chinese Patent Office
McKinsey

Generated: June 19, 2018

DrugPatentWatch Database Preview

Details for Patent: 7,683,051

« Back to Dashboard

Which drugs does patent 7,683,051 protect, and when does it expire?

Patent 7,683,051 protects DUAVEE and is included in one NDA.

This patent has twenty-three patent family members in twenty-one countries.
Summary for Patent: 7,683,051
Title:Crystalline polymorph of bazedoxifene acetate
Abstract: The present invention is directed to a crystalline polymorph of bazedoxifene acetate, compositions containing the same, preparations thereof, and uses thereof.
Inventor(s): Demerson; Christopher (Kirkland, CA), Iera; Silvio (Montreal, CA), Ali; Kadum A. (Congers, NY)
Assignee: Wyeth (Madison, NJ)
Application Number:11/100,983
Patent Claim Types:
see list of patent claims
Compound; Composition; Use; Formulation;

Drugs Protected by US Patent 7,683,051

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Wyeth Pharms Pfizer DUAVEE bazedoxifene acetate; estrogens, conjugated TABLET;ORAL 022247-001 Oct 3, 2013 RX Yes Yes ➤ Sign Up ➤ Sign Up Y Y TREATMENT OF MODERATE TO SEVERE VASOMOTOR SYMPTOMS ASSOCIATED WITH MENOPAUSE ➤ Sign Up
Wyeth Pharms Pfizer DUAVEE bazedoxifene acetate; estrogens, conjugated TABLET;ORAL 022247-001 Oct 3, 2013 RX Yes Yes ➤ Sign Up ➤ Sign Up Y Y PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Merck
AstraZeneca
Queensland Health
Dow
Baxter
Moodys
Chubb
Johnson and Johnson
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.